Presenting Companies

20/20 OptimEyes Technologies is developing a transformative drug delivery platform for ocular diseases normally controlled by eye drops.

Able Innovations is solving the labor-intensive task of lateral patient transfer by developing the ALTA Platform™, a robotic and automated device operated by a single operator.

Arrayus Technologies Inc. is a clinical stage medical device company developing an innovative ultrasound-mediated drug delivery platform for use in oncology.

Artificial Intelligence Imaging Sensors (AiimSense Inc.) - Empowering early stroke diagnosis and monitoring through innovative point-of-care imaging.

Asima Health is redefining cancer surveillance with a simple blood test.

Atorvia is pre-clinical stage biotech company developing novel therapeutics for organ failure with a first-in-class drug in development that prevents and treats ischemic injury, initially targeting the kidney.

BioMimir Inc. is a female-founded medical device company that streamlines wound care using bioabsorbable, liquid to solid biomaterials.

Canurta develops novel bioactive products to support inflammation across diverse diseases.

Celestra Health proactively detects Multiple Sclerosis (MS) disease progression before irreversible damage occurs. We use wearable technology powered by our patented AI algorithms to measure disease progression with laboratory-grade precision, at 1/100th of the cost of a state-of-the-art laboratory.

Clairvoyant Therapeutics is a late stage clinical stage biotechnology company changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the EU & Canada to treat patients living with Alcohol Use Disorder (AUD) beginning in 2026.

Cobionix Corporation is a robotics company developing fully autonomous cobots for procedural, repetitive, and complex tasks. The cobots will work collaboratively in the healthcare space to reduce gaps and increase consistency.

Conavi Medical is an early commercial-stage medical device company that has developed the first and only intravascular imaging system that combines ultrasound (IVUS) and optics (OCT) for coronary visualization.

Cove Neurosciences is developing software to enable a new era of precision biomarkers for neurologic and psychiatric diseases, with the goal of developing objective metrics to inform novel therapies for neurological and psychiatric disorders.

Cura Therapeutics is a preclinical (POC) stage biotech company, entering IND-enabling studies in Q1 2024, developing a first-in-class multifunctional immunotherapy drug pipeline to treat a wide range of solid malignancies and infectious diseases. Cura's immunotherapies harness cytokines and receptors to create multifunctional proteins with potent anti-cancer and anti-viral properties.

Difinity Solutions is developing NeedSwitch, the world's first interchangeable and modular autoinjector for emergency medication delivery. It is designed to save lives starting with the opioid crisis, a market worth over $4B per year with further platform applications for other various emergency medications.

Eyam Vaccines and Immunotherapeutics Ltd - Platform technologies that create vaccines and immunotherapeutics on demand.

Fibra Inc. is a data-driven women's health platform, with their patent-pending smart underwear plus an app.

FluidAI is a Canadian MedTech company focused on harnessing the power of AI to deliver a new standard of postoperative care.

Fluid Biomed - The company team of neurosurgeons, scientists, and engineers has designed the world’s first hybrid polymer-metal flow-diverting stent to cure this deadly disease.

FOCUS Oncology is developing novel targeted therapies for pancreatic cancer patients. FOCUS is in-licensing a highly active and well tolerated targeted antibody therapeutic currently in a phase II trial, with a FDA Fast Track Designation.  Coupled with driving the widespread adoption of next-gen molecular subtyping, FOCUS will accelerate the development of this antibody through to registration in pancreatic cancer.  In addition, molecular data generated will be analyzed using a proprietary bespoke bioinformatic platform (TITAN™) to identify novel pancreatic cancer biomarkers for disease screening, treatment, and monitoring.

FOQUS Technologies is tackling the MRI accessibility problem by developing a cloud-based MRI software solution that can reduce scan time, from 60 minutes to less than 5 minutes, without sacrificing imaging quality.

Genomadix is a validated, late stage point of care molecular diagnostic company focused on genotype guided precision medicine and open platform partnerships for adjacent verticals of infectious disease, animal diagnostics and food safety, now entering high growth commercialization.

HeadFirst is revolutionizing concussion testing with saliva based screening.

JVP Labs is a Congestive Heart Failure (CHF) remote patient monitoring start-up. Our single device provides automated, hospital quality vital sign work up, including Jugular Venous Pressure (JVP) height, in less than 1 minute a read. The system is non invasive, cost effective and easily deployed by elderly patients.

MACH32 is revolutionizing pre-hospital hemorrhage management by developing an "EpiPen" for trauma.

mDETECT is a liquid biopsy company that has developed highly specific and sensitive blood tests for detection and management of numerous cancers including, but not limited to, breast, prostate, ovarian, pancreatic, lung, uveal melanoma, and colorectal with applications in monitoring treatment response, minimal residual disease, and early detection of relapse.

Meridius Bio - Our innovative, derisked AIMER Nanotechnology (Activated Immuno-Modulated Enhanced Regeneration) has been proven to reduce wound healing time by 50-70%, and is ready for clinical development.

Molecular You is the first and only multi-biomarker analytics platform, providing decision support to clinicians and ACOs based on highly accurate predictive risk profiles in 26+ health areas.

Momentum Health is an AI-based digital health platform for remotely managing spine care.

NextUp Care is automating healthcare – one appointment at a time.

Noa Therapeutics is a preclinical biotech company pioneering the development of non-steroidal, tri-modal small molecules to address the complexity of inflammatory barrier diseases by simultaneously targeting three key disease drivers to reduce the cycle of treatment failures.

PhenoTips software is the leading solution for medical genetics used in the US, UK and Canada to address the challenges faced in medical genetics with a single solution, while preparing for the proliferation of genetic testing into mainstream healthcare.

ProteocyteAI is a health technology company that has developed a platform technology with the first application already launched and selling: a test that predicts the risk of progression of oral pre-malignant lesions to invasive cancer.

PurMinds is a neuro drug development and API supply company focused on promoting neuroplasticity and neuro-rejuvenation.

Founded by orthopaedic surgeons, Reach Orthopaedics has developed a shoulder implant to treat middle-aged patients suffering from massive irreparable rotator cuff tears. Reach's shoulder implant is designed to restore shoulder function and reduce chronic pain. It is durable and non-migratory, making it ideal for the middle-aged demographic.

Realize Medical specializes in the application of modern mixed-reality technology to medical imaging and surgical planning, offering an FDA-cleared software platform for collaboratively creating and visualizing 3D anatomical models for use in planning complex medical procedures.

Rhythm Biotherapeutics Inc. - Rhythm Biotherapeutics Inc. is commercializing exosome-based therapies for the prevention and cure of atrial fibrillation, beginning with strong pre-clinical evidence for preventing postoperative atrial fibrillation (POAF), their initial candidate therapy.

Rocket Doctor is a digital health platform and marketplace that intelligently matches patients with the best clinician for their needs while utilizing AI-fueled software, a unique support system and remote medical devices, and allows clinicians to build and run independent virtual practices, directed to patients on Medicaid and in rural/remote communities across Canada.

Scanbo Technologies - Medical diagnostics in the palm of your hand, results in under 5 minutes. No lab required.

Scispot is an AI toolkit for stitching and transforming R&D data. It enables the integration of disparate data and prepares it for machine learning, visualization, and auditing. Scispot accomplishes this by providing a staging lakehouse (data lake) specifically designed for Biotech applications.

Sonaro's AI-driven diagnostic imaging software overcomes the limitations of traditional 2D ultrasound imaging by empowering clinicians with precise 3D reconstructed models of the carotid artery and an automated plaque detection, and stroke risk analysis, ultimately reducing operator dependency and examination duration, while saving lives through accurate diagnosis and earlier intervention.

Sonic Incytes is a commercial-stage company with an FDA cleared AI-assisted ultrasound technology revolutionizing the way we diagnose chronic liver disease, a global epidemic affecting over a billion people and causing two million deaths annually.

Synakis has developed a novel ocular biomaterial for use as a vitreous substitute for retinal surgery and to deliver engineered therapeutics to treat leading causes of blindness.

Trexo Robotics is building exoskeletons to help people walk, starting with children with disabilities.

Triple Hair is a clinical-stage biotechnology company dedicated to the development of innovative treatments for androgenic alopecia.

Vasomune is a clinical stage biotech focused on combating vascular dysfunction to stabilize the body as it battles disease.

Vessl Prosthetics helps empower amputees to overcome obstacles and realize their full potential.

XPAN - Traditional trocar access is still dangerous, costly and inflexible. Xpan has challenged the current standard of care and maximized the potential of MIS access technologies by creating one trocar enabling all instruments.

Zilia is a health technology company developing a breakthrough platform to measure biomarkers in the eye, to prevent diagnose and treat various ocular, neurological and systemic conditions.